Study finds weight-loss drugs like Ozempic may reduce risk of 42 health conditions in diabetes patients

A new study suggests that weight-loss drugs like Ozempic may lower the risk of 42 health conditions in people with type 2 diabetes. This includes a reduced risk of cardiovascular disease and surprising findings like lower chances of psychotic disorders and Alzheimer's. The research analyzed health records of nearly 216,000 diabetes patients using GLP-1 receptor antagonists, comparing them to those on other treatments. While some risks, such as nausea, were expected, others, like increased joint pain, were unexpected. The study is observational, meaning its findings are not definitive. Experts caution that results should be interpreted carefully, as they may be influenced by factors not measured in the study. Further randomized trials are needed for stronger evidence.